Rietmeijer Cornelis A, Hopkins Emily, Geisler William M, Orr Donald P, Kent Charlotte K
Denver Public Health Department, University of Colorado at Denver and Health sciences Center, Denver, Colorado, USA.
Sex Transm Dis. 2008 Nov;35(11 Suppl):S8-S18. doi: 10.1097/OLQ.0b013e31816938ba.
The cost-effectiveness of screening men for Chlamydia trachomatis depends in part on the prevalence of chlamydia in the screened population and the ease with which screening programs can be implemented. Screening in venues with high rates of chlamydia positivity among men may therefore be an important adjunct to chlamydia control. To evaluate the recent US literature on chlamydia positivity in chlamydia screening programs among asymptomatic men in nonsexually transmitted disease clinic settings, we reviewed published articles between 1995 and June 2007, using PubMed as the primary search tool. Articles were abstracted and positivity rates summarized by type of venue, race/ethnicity, age group, and US region. The overall median positivity rate was 5.1%. The highest rates were observed among men tested in juvenile (7.9%) and adult (6.8%) detention facilities, among blacks (6.7%), the 15 to 19 years old (6.1%) and 20 to 24 years old (6.5%) age groups, and among men screened in the southern United States (6.4%). Chlamydia rates among men are high in certain venues, particularly correctional settings, but also depend on the demographic composition of the target population and location. Programs considering male chlamydia screening programs should conduct pilot programs to assess chlamydia positivity as well as feasibility and cost in target venues.
对男性进行沙眼衣原体筛查的成本效益部分取决于被筛查人群中衣原体的流行率以及筛查项目实施的难易程度。因此,在男性衣原体阳性率较高的场所进行筛查可能是衣原体控制的一项重要辅助措施。为了评估美国近期关于非性传播疾病诊所环境中无症状男性衣原体筛查项目中衣原体阳性情况的文献,我们以PubMed作为主要检索工具,回顾了1995年至2007年6月发表的文章。文章被提取摘要,并按场所类型、种族/族裔、年龄组和美国地区总结阳性率。总体中位阳性率为5.1%。在青少年(7.9%)和成人(6.8%)拘留所接受检测的男性、黑人(6.7%)、15至19岁(6.1%)和20至24岁(6.5%)年龄组的男性以及在美国南部接受筛查的男性(6.4%)中观察到最高的阳性率。男性中的衣原体感染率在某些场所较高,特别是教养机构,但也取决于目标人群的人口构成和地点。考虑开展男性衣原体筛查项目的机构应开展试点项目,以评估目标场所的衣原体阳性情况以及可行性和成本。